0001127602-24-003099.txt : 20240202 0001127602-24-003099.hdr.sgml : 20240202 20240202160751 ACCESSION NUMBER: 0001127602-24-003099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240202 FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MIZELL STEVEN CENTRAL INDEX KEY: 0001189403 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 24591427 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-02-02 0000310158 Merck & Co., Inc. MRK 0001189403 MIZELL STEVEN MERCK & CO., INC. 126 EAST LINCOLN AVENUE RAHWAY NJ 07065 1 EVP, Chief HR Officer 0 Common Stock 2024-02-02 4 M 0 824 70.71 A 42143.145 D Common Stock 2024-02-02 4 M 0 32170 73.73 A 74313.145 D Common Stock 2024-02-02 4 S 0 50694 126.6491 D 23619.145 D Stock Option (Right to Buy) 70.71 2024-02-02 4 M 0 824 0 D 2019-10-30 2028-10-29 Common Stock 824 0 D Stock Option (Right to Buy) 73.73 2024-02-02 4 M 0 32170 0 D 2022-05-04 2031-05-03 Common Stock 32170 22088 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4300 to $126.9000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vested and became exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024. /s/ Kelly E. W. Grez as Attorney-in-Fact for Steven C. Mizell 2024-02-02